Literature DB >> 6289857

Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521.

J A Millar, F H Derkx, K McLean, J L Reid.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6289857      PMCID： PMC1427629          DOI： 10.1111/j.1365-2125.1982.tb01990.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  27 in total

1.  A sensitive radioenzymatic assay for norepinephrine in tissues and plasma.

Authors:  D P Henry; B J Starman; D G Johnson; R H Williams
Journal:  Life Sci       Date:  1975-02-01       Impact factor: 5.037

2.  A liquid chromatography-assisted assay for angiotensin-converting enzyme (peptidyl dipeptidase) in serum.

Authors:  S G Chiknas
Journal:  Clin Chem       Date:  1979-07       Impact factor: 8.327

3.  Control of enzymatically inactive renin in man under various pathological conditions: implications for the interpretation of renin measurements in peripheral and renal venous plasma.

Authors:  F H Derkx; G J Wenting; A J Man in 't Veld; R P Verhoeven; M A Schalekamp
Journal:  Clin Sci Mol Med       Date:  1978-05

4.  Haemodynamics of orally-active converting enzyme inhibitor (SQ 14225) in hypertensive patients.

Authors:  R J Cody; R C Tarazi; E L Bravo; F M Fouad
Journal:  Clin Sci Mol Med       Date:  1978-11

5.  Role of the renin-angiotensin system in blood pressure regulation. The cardiovascular effects of converting enzyme inhibition in normotensive subjects.

Authors:  A P Niarchos; T G Pickering; D B Case; P Sullivan; J H Laragh
Journal:  Circ Res       Date:  1979-12       Impact factor: 17.367

6.  Improved assay methods for renin "concentration" and "activity" in human plasma. Methods using selective denaturation of renin substrate.

Authors:  S L Skinner
Journal:  Circ Res       Date:  1967-04       Impact factor: 17.367

7.  Facilitation of adrenergic transmission by locally generated angiotensin II in rat mesenteric arteries.

Authors:  K U Malik; A Nasjletti
Journal:  Circ Res       Date:  1976-01       Impact factor: 17.367

8.  Increased glomerular filtration rate after converting-enzyme inhibition in essential hypertension.

Authors:  N K Hollenberg; S L Swartz; D R Passan; G H Williams
Journal:  N Engl J Med       Date:  1979-07-05       Impact factor: 91.245

9.  Heart rate and oxygen uptake response to angiotensin in the squirrel monkey at 10 degrees C.

Authors:  N Wasserstrum; J A Herd
Journal:  Am J Physiol       Date:  1977-07

10.  Inhibition by angiotensin II of baroreceptor-evoked activity in cardiac vagal efferent nerves in the dog.

Authors:  E R Lumbers; D I McCloskey; E K Potter
Journal:  J Physiol       Date:  1979-09       Impact factor: 5.182
View more
  45 in total

1.  The influence of cilazapril on indices of autonomic function in normotensives and hypertensives.

Authors:  H L Elliott; A A Ajayi; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

2.  Age and the pharmacodynamics of angiotensin converting enzyme inhibitors enalapril and enalaprilat.

Authors:  A A Ajayi; N Hockings; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1986-04       Impact factor: 4.335

Review 3.  Preclinical studies on angiotensin converting enzyme inhibitors.

Authors:  I L Natoff
Journal:  Cardiovasc Drugs Ther       Date:  1987       Impact factor: 3.727

4.  The effect of angiotensin II on endogenous noradrenaline release in man.

Authors:  P H Seidelin; W J Coutie; A D Struthers
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

5.  Effect of captopril on changes in plasma noradrenaline induced by sodium nitroprusside.

Authors:  R H Becker; A D Struthers; M J Brown
Journal:  Br J Clin Pharmacol       Date:  1986-10       Impact factor: 4.335

Review 6.  Inhibitors of the angiotensin I converting enzyme as antihypertensive drugs.

Authors:  P A Van Zwieten; A De Jonge; P B Timmermans
Journal:  Pharm Weekbl Sci       Date:  1983-10-21

7.  Concentration effect modelling with converting enzyme inhibitors in man.

Authors:  A W Kelman; J L Reid; J A Millar
Journal:  Br J Clin Pharmacol       Date:  1983-04       Impact factor: 4.335

8.  Enalapril (MK421) and its lysine analogue (MK521): a comparison of acute and chronic effects on blood pressure, renin-angiotensin system and sodium excretion in normal man.

Authors:  G P Hodsman; J R Zabludowski; C Zoccali; R Fraser; J J Morton; G D Murray; J I Robertson
Journal:  Br J Clin Pharmacol       Date:  1984-03       Impact factor: 4.335

9.  Captopril: pharmacokinetics, antihypertensive and biological effects in hypertensive patients.

Authors:  C Richer; B Giroux; P F Plouin; B Maarek; J F Giudicelli
Journal:  Br J Clin Pharmacol       Date:  1984-03       Impact factor: 4.335

10.  Lisinopril versus atenolol: decrease in systolic versus diastolic blood pressure with converting enzyme inhibition.

Authors:  B E Pannier; V G Garabedian; O Madonna; M Fouchard; B Darne; M E Safar
Journal:  Cardiovasc Drugs Ther       Date:  1991-08       Impact factor: 3.727
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.